Dermal fillers injection is the most popular wrinkle treatment. , the worldwide dermal fillers market in 2020 exceeded USD 6.7 billion and grew by 8% annually for the last 10 years.

The most popular non-invasive procedures today are Botox injections and Dermal filler injections.

​

The primary market leading dermal fillers manufacturing companies are Allergan, Galderma, and Merz.  

​

The end-users are all practitioners who are allowed to inject dermal fillers.

​

The practitioners purchase dermal fillers syringes from dermal fillers manufacturers and manually inject dermal fillers to patients.

​

Currently, only highly skilled practitioners perform dermal filler injections, which is a small share of the market potential (about 14,000,000 syringes were injected worldwide during 2020)

​

Agyless device automates the facial filler injection procedure and eliminates both the complications and adverse effects caused by incorrect injection technique.

​

Agyless device creates an opportunity to further increase the dermal filler sales in the existing market and to open a new market segment of practitioners who are permitted by law to inject dermal fillers but have not previously injected due to lack of experience. The ease of use and safety will facilitate an increase in the number of procedures performed by non-skilled practitioners, as well as encourage hesitant patients to undergo filler treatment.

​

The introduction of the Agyless device will increase the dermal fillers sales dramatically by providing safety and excellent results independent of practitioners' skills or experience. We expect increased demand as potential patients understand the safety advantage, increased comfort, and better results offered by Agyless over the manual injection method. Wide acceptance of the Agyless device will turn it into the gold- standard for dermal filler injections. The demand from patients will further encourage practitioners to adopt the use of Agyless device, further increasing its popularity.